Discovery and Development of Antibacterial Peptidoglycan Hydrolase Inhibitors
Kyong Tkhe Fam1, Pavan Kumar Chodisetti1, Howard C Hang1,2
1Department of Immunology and Microbiology, Scripps Research, La Jolla, California 92037, United States.
None:
The growing number of bacterial infections and the rise of antibiotic resistance require approaches for antimicrobial development. Peptidoglycan, essential for maintaining the integrity and shape of the bacterial cell wall, is regulated by the coordinated activity of peptidoglycan synthesis and remodeling enzymes. While peptidoglycan synthesis enzymes have served as antibiotic targets for decades, peptidoglycan hydrolases have remained largely underexplored. Here, we review recent advances in the development of small-molecule inhibitors of peptidoglycan hydrolases as antimicrobial targets.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:57Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Related Concept Videos
Peptidoglycan Synthesis
Lysosomal Hydrolases
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Drug Discovery: Overview
Dipeptidyl Peptidase 4 Inhibitors
Sustainable Development
